Oct 6, 2021IpiNovyx Bio Closes on $10 Million Seed Financing Round to Advance Proprietary Platform The following was taken from Trialsitenews--continue reading here "New York-based IpiNovyx Bio announced the closing of a $10 million...
Oct 6, 2021IpiNovyx Bio closes $10 million seed financing roundThe below is an excerpt taken from EndPoints News. Read more here or continue reading below. "With a focus on autoimmune and inflammatory...
Oct 6, 2021Eli Lilly-backed IpiNovyx Bio emerges with $10M for 2023 clinical entryWe are excited to announce our launch! The following was taken from Fierce Biotech--read it here or continue below! "Eli Lilly is among...